Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Capital Expenditures (2021 - 2026)

ADC Therapeutics has reported Capital Expenditures over the past 6 years, most recently at $32000.0 for Q1 2026.

  • Quarterly results put Capital Expenditures at $32000.0 for Q1 2026, down 87.88% from a year ago — trailing twelve months through Mar 2026 was $32000.0 (down 94.67% YoY), and the annual figure for FY2025 was $264000.0, down 69.55%.
  • Capital Expenditures reached $32000.0 in Q1 2026 per ADCT's latest filing, down from $264000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $2.6 million in Q3 2023 and bottomed at -$2.8 million in Q4 2023.
  • Median Capital Expenditures over the past 5 years was $32000.0 (2026), compared with a mean of $94470.3.
  • The largest annual shift saw Capital Expenditures crashed 123784.21% in 2023 before it soared 129.36% in 2024.
  • Over 5 years, Capital Expenditures stood at $114.0 in 2022, then plummeted by 2477292.98% to -$2.8 million in 2023, then skyrocketed by 129.36% to $829000.0 in 2024, then crashed by 68.15% to $264000.0 in 2025, then plummeted by 87.88% to $32000.0 in 2026.
  • Business Quant data shows Capital Expenditures for ADCT at $32000.0 in Q1 2026, $264000.0 in Q4 2025, and -$264000.0 in Q3 2025.